0337 GMT - Navigator Global Investments' bull at Morgans reckons the alternative-asset manager's momentum is intact despite its slight annual earnings miss. Analyst Richard Coles tells clients in a note that the Australian company's underlying Ebitda for the 12 months through June was about 3% below consensus. However, Coles points out that inflows look set to continue into the current fiscal year and that Navigator's recently acquired stable portfolio is performing in line with expectations. He lowers his annual adjusted profit forecasts through fiscal 2029 by between 4.2% and 4.5%, but keeps a buy rating on the stock. Morgans trims its target price 2.9% to 3.04 Australian dollars. Shares are up 6.7% at A$2.56. (stuart.condie@wsj.com)

0230 GMT - Bendigo & Adelaide Bank still isn't offering anything to UBS analysts that would justify a rerating of its stock. With an unchanged neutral rating on the stock, the analysts say the Australian bank is improving operationally without presenting a catalyst for them to become more bullish. The UBS analysts tell clients in a note that fiscal 2027 will be a harder year for the regional lender, pointing to the overhang of regulatory scrutiny and emerging pressure on mortgage margins. Quicker progress by the bank on reducing costs or hitting its return-on-equity target would be catalysts for a more positive view, they add. UBS cuts its target price by 7.1% to 10.50 Australian dollars. Shares are up 3.4% at A$10.81. (stuart.condie@wsj.com)

0217 GMT - Bendigo & Adelaide Bank's cost guidance implies material risk to the consensus forecast for fiscal 2028 earnings, Macquarie analysts warn. They tell clients in a note that Bendigo's expectation that business-as-usual costs will grow by 4%-5% in fiscal 2027 sits above the regional lender's medium-term guidance. They think that the next year or two will be challenging, with margin headwinds outweighing fading tailwinds, credit growth slowing, and increased focus on regulatory standards. Ultimately, they think return on equity is capped at 7%, well below Bendigo's 10% target. Macquarie keeps an underperform rating on the stock with an unchanged target price of 9.00 Australian dollars. Shares are up 3.6% at A$10.83. (stuart.condie@wsj.com)

0048 GMT - Woodside Energy's 1H result may have been well signaled in advance, but it still created several questions for Jarden. Woodside reported an underlying profit of US$1.33 billion, beating Jarden's estimate by 1%. Analyst Nik Burns expects the focus to be on Woodside's business review. Woodside plans to strip out US$350 million of costs, leading Jarden to seek detail on the composition of that program. Woodside also will carry out a strategic review of its Beaumont New Ammonia project in Texas. Jarden ponders whether this implies the likely sale and exit from the asset. It had an overweight call and A$32.20 price target on Woodside ahead of the result. Woodside is up 2.4% to A$34.29. (david.winning@wsj.com; @dwinningWSJ)

0044 GMT - Ansell's exposure to economic cycles, input-cost inflation and currency moves make it hard for the personal-protective equipment maker to deliver consistent growth, UBS analysts warn. Maintaining a neutral rating on the stock, the analysts tell clients in a note they are encouraged by Ansell's strong June-half performance but that a focus on organic revenue growth is nothing new for the company. They like Ansell's stronger-than-expected earnings guidance but see a potential second-half revenue headwind from a reduction in synthetic glove prices, pointing to a recent fall in oil-derived input costs. UBS lifts its target price 13% to 38.70 Australian dollars. Shares are up 6.3% at A$40.65. (stuart.condie@wsj.com)

0038 GMT - Ansell's stronger-than-expected earnings guidance isn't enough to turn Macquarie analysts more bullish on the stock. They raise their fiscal 2027 adjusted EPS forecast to the midpoint of the personal-protective equipment maker's guidance range, but point out that management will look to unwind recent price increases if inflation falls. This is enough to keep them cautious, they tell clients in a note. The Macquarie analysts think the 9.6% share-price jump that followed this week's fiscal 2026 result announcement left the stock fairly valued. Macquarie stays neutral on the stock and lifts its target price 9.3% to 38.60 Australian dollars. Shares are up 5.75% at A$40.44. (stuart.condie@wsj.com)

0037 GMT - Viva Energy's refinery operation is being supported by the Middle East conflict, but the company isn't doing as well as rival Ampol in capturing the tailwind to margins. Viva Energy said its refining margin was US$20.70 per barrel in July. That was below the US$27.11 per barrel reported by Ampol yesterday for the same month. Jefferies analyst Michael Simotas attributes the difference to the fire at Viva Energy's Geelong refinery in April, which curbed some production. Jefferies also says Viva Energy needs to articulate the earnings base of its Convenience Retail business. "We believe Ampol is a better way to play the sector," it says. Viva Energy is down 3.0% at A$2.765. (david.winning@wsj.com; @dwinningWSJ)

0029 GMT - Australian mall owner Scentre's share price falls 1.6% to A$3.61 despite management upgrading its annual guidance for earnings and distributions. Scentre now expects funds from operations of at least 23.79 Australian cents per security in 2026. It also raised its distribution forecast to 18.473 Australian cents per security. Jefferies notes the revised guidance falls short of its own expectation for FFO of 23.9 Australian cents/security. "We wouldn't expect material consensus FFO/security revisions following today's results," analyst Andrew Dodds says. Jefferies had a buy call and A$4.36/share price target on Scentre heading into today's result. (david.winning@wsj.com; @dwinningWSJ)

0025 GMT - Coles's recent supermarket sales look better than Citi feared. Coles said sales growth in the first eight weeks of FY27 was consistent with what it achieved in 4Q, which was 3.8% when tobacco is excluded, or 3.3% on a comparable basis. "We had expected material weakness given the very strong Ooshies promotion from Woolworths that ran for most of this period," says analyst Adrian Lemme. Coles acknowledged that Woolworths's campaign weighed on its sales for a period, but said trends are now back in line with 4Q26. Citi had a buy call on Coles heading into today's annual result. Coles is down 0.3% at A$22.57. (david.winning@wsj.com; @dwinningWSJ)

2336 GMT -- Monadelphous expects a year of consolidation in FY27. The market expects it to have one, too. "MND referred to FY27 being a year of consolidation and being able to position for future growth," RBC Capital Markets says following the engineering company's FY26 results. That is in line with previous remarks by management, who at the 1H FY26 result said that delivering growth in FY27 would be challenging, says the broker. "Importantly, current FY27 consensus NPAT [net profit] expectations are A$129 million, flat versus today's FY26 print," it says. RBC has a sector perform rating and A$31.00 target on Monadelphous. Shares ended Monday at A$32.27. (rhiannon.hoyle@wsj.com; @RhiannonHoyle)

2347 GMT - Monadelphous expects a year of consolidation in FY 2027. The market expects it to have one, too. "MND referred to FY27 being a year of consolidation and being able to position for future growth," RBC Capital Markets says following the engineering company's FY 2026 results. That is in line with previous remarks by management, who at the 1H FY 2026 result said that delivering growth in FY 2027 would be challenging, says the broker. "Importantly, current FY27 consensus NPAT [net profit] expectations are A$129 million, flat versus today's FY26 print," it says. RBC has a sector perform rating and A$31.00 target on Monadelphous. Shares ended Monday at A$32.27. (rhiannon.hoyle@wsj.com; @RhiannonHoyle)

Monadelphous reports a solid FY result, with Ebitda and net profit both 1% higher than consensus, says Barrenjoey. The bank attributes the modest beats to tax and interest revenue. The engineering company's cash result is well ahead of consensus, with operating cash flow a 28% beat, Barrenjoey says. It notes that the stock outperformed heading into the result. Monadelphous says FY27 will be a year to consolidate and position for future growth. "We think a key question on the call will be quantum and drivers of revenue base in FY27 to position for growth," Barrenjoey says. It has an overweight rating and A$31.10 target on Monadelphous. Shares ended Monday at A$32.37. (rhiannon.hoyle@wsj.com; @RhiannonHoyle)

2244 GMT -- Ansell's bull at Jefferies is impressed at how the personal-protective equipment maker managed to raise prices while simultaneously delivering on strategy and acquisition integration. Maintaining a buy rating on the stock, analyst Vanessa Thomson tells clients in a note that she expects positive momentum to continue into the current fiscal year, with sales growth and productivity gains in the cards. Thomson likes how Ansell has refined supply chains and improved sourcing productivity in response to heightened geopolitical uncertainty, and thinks this will continue. Jefferies raises its target price on the ASX-listed stock 16% to 44.50 Australian dollars. Shares are at A$38.24 ahead of the open.